• 1. An investigation on the second-order nonlinear optical response of cationic bipyridine or phenanthroline iridium(iii) complexes bearing cyclometallated 2-phenylpyridines with a triphenylamine substituent?
  David B. Cordes,Alexandra M. Z. Slawin,Stefania Righetto,Denis Jacquemin,Eli Zysman-Colman,Véronique Guerchais Dalton Trans., 2018,47, 8292-8300
• 2. An intermolecular C–C coupling reaction of iridium complexes?
  Kathrin Kutlescha,Rhett Kempe New J. Chem., 2010,34, 1954-1960
• 3. An antioxidant self-healing hydrogel for 3D cell cultures?
  Lei Yang,Yuan Zeng,Haibo Wu,Chunwu Zhou,Lei Tao J. Mater. Chem. B, 2020,8, 1383-1388
• 4. An approach to the structure and vibrational analysis of cis- and trans-3-chlorostyrene through IR/Raman and INS spectroscopies and theoretical ab initio/DFT calculations?
  J. M. Granadino-Roldán,M. Fernández-Gómez,A. Navarro,T. Pe?a Ruiz,U. A. Jayasooriya Phys. Chem. Chem. Phys., 2004,6, 1133-1143
• 5. An aptamer-based keypad lock system?
  Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Monosaccharides
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbohydrates and carbohydrate conjugates Monosaccharides

Recent Advances in the Study of Methyl 4,6-dichloro-4,6-dideoxy-a-D-galactopyranoside (CAS: 4990-82-3)

Methyl 4,6-dichloro-4,6-dideoxy-a-D-galactopyranoside (CAS: 4990-82-3) is a chemically modified carbohydrate derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry. Recent studies have explored its potential applications in drug development, particularly as a precursor or intermediate in the synthesis of novel therapeutic agents. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical properties, synthetic pathways, and biological activities.

One of the key areas of interest is the role of Methyl 4,6-dichloro-4,6-dideoxy-a-D-galactopyranoside in the synthesis of glycosidase inhibitors. Glycosidases are enzymes involved in the breakdown of glycosidic bonds, and their inhibitors have potential applications in treating diseases such as diabetes, viral infections, and cancer. Recent research has demonstrated that modifications to the galactopyranoside scaffold, including the introduction of chloro substituents at the 4 and 6 positions, can enhance the inhibitory activity and selectivity of these compounds.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the synthetic routes to Methyl 4,6-dichloro-4,6-dideoxy-a-D-galactopyranoside and its analogs. The study highlighted the efficiency of a one-pot chlorination-deoxygenation strategy, which significantly improved the yield and purity of the target compound. Furthermore, the researchers explored the compound's stability under various physiological conditions, providing valuable insights for its potential use in drug formulations.

Another recent study, published in Bioorganic & Medicinal Chemistry Letters, focused on the biological evaluation of Methyl 4,6-dichloro-4,6-dideoxy-a-D-galactopyranoside derivatives. The findings revealed that these compounds exhibit promising activity against bacterial glycosidases, suggesting their potential as antimicrobial agents. The study also identified key structural features that contribute to their bioactivity, paving the way for the design of more potent derivatives.

Beyond its applications in glycosidase inhibition, Methyl 4,6-dichloro-4,6-dideoxy-a-D-galactopyranoside has also been explored as a building block for the synthesis of glycoconjugates. Glycoconjugates play critical roles in cell-cell interactions and immune responses, and their synthetic analogs have potential applications in vaccine development and targeted drug delivery. Recent advancements in carbohydrate chemistry have enabled the efficient incorporation of this compound into complex glycoconjugate structures, further expanding its utility in biomedical research.

In conclusion, Methyl 4,6-dichloro-4,6-dideoxy-a-D-galactopyranoside (CAS: 4990-82-3) represents a versatile and valuable compound in the field of chemical biology and medicinal chemistry. Recent studies have shed light on its synthetic accessibility, biological activities, and potential therapeutic applications. As research in this area continues to advance, this compound is likely to play an increasingly important role in the development of novel drugs and biomedical tools.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)